- Efficacy of Androgen Deprivation Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Docetaxel-Based Chemotherapy
-
Min K, Chung JW, Ha YS, Lee JN, Kim BS, Kim HT, Kim TH, Yoo ES, Kwon TG, Chung SK, Tanaka M, Egawa S, Kimura T, Choi SH
- KMID: 2471829
- World J Mens Health.
- 2020 Apr;38(2):226-235.
- doi: 10.5534/wjmh.190029
PURPOSE: The purpose of this study was to determine the comparative effectiveness of androgen deprivation therapy (ADT) combined with docetaxel (DTX)-based chemotherapy in Korean and Japanese castration-resistant prostate cancer (CRPC)... -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnostic Performance of 68Gallium Labelled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging for Staging the Prostate Cancer with Intermediate or High Risk Prior to Radical Prostatectomy: A Systematic Review and Meta-analysis
-
Wu H, Xu T, Wang X, Yu YB, Fan ZY, Li DX, Luo L, Yang XC, Jiao W, Niu HT
- KMID: 2471827
- World J Mens Health.
- 2020 Apr;38(2):208-219.
- doi: 10.5534/wjmh.180124
PURPOSE: To compare the diagnostic efficiency of â¶â¸Gallium labelled prostate-specific membrane antigen positron emission tomography (â¶â¸Ga-PSMA PET) and magnetic resonance imaging (MRI) for staging the lymph node metastases (LNMs) in... -
- CITED
-
- Close
- SHARE
-
- Close
- Bone Health Issues in Patients with Prostate Cancer: An Evidence-Based Review
-
Walz S, Maas M, Stenzl A, Todenhöfer T
- KMID: 2471822
- World J Mens Health.
- 2020 Apr;38(2):151-163.
- doi: 10.5534/wjmh.190044
Bone health in prostate cancer patients represents a prerequisite for acceptable quality of life and optimal outcome of this disease. The major threat for bone health in prostate cancer displays... -
- CITED
-
- Close
- SHARE
-
- Close
- Prostate Cancer Mortality and Use of 5-Alpha Reductase Inhibitors
-
Foldes CA, Wang R, Canfield S
- KMID: 2471820
- World J Mens Health.
- 2020 Apr;38(2):139-140.
- doi: 10.5534/wjmh.190129
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Guidelines for Transrectal Ultrasonography-Guided Prostate Biopsy: Korean Society of Urogenital Radiology Consensus Statement for Patient Preparation, Standard Technique, and Biopsy-Related Pain Management
-
Lee MS, Moon MH, Kim CK, Park SY, Choi MH, Jung SI, Korean Society of Urogenital Radiology (KSUR)
- KMID: 2471808
- Korean J Radiol.
- 2020 Apr;21(4):422-430.
- doi: 10.3348/kjr.2019.0576
The Korean Society of Urogenital Radiology (KSUR) aimed to present a consensus statement for patient preparation, standard technique, and pain management in relation to transrectal ultrasound-guided prostate biopsy (TRUS-Bx) to... -
- CITED
-
- Close
- SHARE
-
- Close
- Single-port robot-assisted radical prostatectomy with the da Vinci SP system: A single surgeon's experience
-
Kim KH, Song W, Yoon H, Lee DH
- KMID: 2471073
- Investig Clin Urol.
- 2020 Mar;61(2):173-179.
- doi: 10.4111/icu.2020.61.2.173
PURPOSE: To report an initial single-surgeon experience with single-port robot-assisted radical prostatectomy (SP-RARP) using the da Vinci SP surgical system (Intuitive Surgical, USA). MATERIALS AND METHODS: Between December 2018 and October... -
- CITED
-
- Close
- SHARE
-
- Close
- BRCA1-associated protein 1 expression and prognostic role in prostate adenocarcinoma
-
Oh H, Lee YJ, Kang SG, Ahn B, Kim E, Chae YS, Lee Y, Lee JH, Kim CH
- KMID: 2471072
- Investig Clin Urol.
- 2020 Mar;61(2):166-172.
- doi: 10.4111/icu.2020.61.2.166
PURPOSE: As prostate cancer (PCa) is the second most commonly diagnosed cancer worldwide, finding novel markers for prognosis is crucial. BRCA1-associated protein 1 (BAP-1), a nuclear-localized deubiquitinating enzyme, has been... -
- CITED
-
- Close
- SHARE
-
- Close
- Targeted next-generation sequencing for locally advanced prostate cancer in the Korean population
-
Suh J, Jeong CW, Choi S, Ku JH, Kim HH, Kim KS, Kwak C
- KMID: 2471068
- Investig Clin Urol.
- 2020 Mar;61(2):127-135.
- doi: 10.4111/icu.2020.61.2.127
PURPOSE: This study aimed to evaluate the feasibility of pan-cancer panel analysis for locally advanced prostate cancer in the Korean population. MATERIALS AND METHODS: We analyzed 20 patients with locally advanced... -
- CITED
-
- Close
- SHARE
-
- Close
- Current trends in minimally invasive surgery for benign prostatic hyperplasia
-
Choo MS, Son H
- KMID: 2470067
- J Korean Med Assoc.
- 2020 Feb;63(2):119-125.
- doi: 10.5124/jkma.2020.63.2.119
The prevalence of benign prostatic hyperplasia (BPH) is rising with Korea becoming an aging society. As patients age, their comorbidities and the risks associated with anesthesia increase. Recently, there has... -
- CITED
-
- Close
- SHARE
-
- Close
- The human gastrointestinal microbiota and prostate cancer development and treatment
-
Sha S, Ni L, Stefil M, Dixon M, Mouraviev
- KMID: 2469125
- Investig Clin Urol.
- 2020 Feb;61(Suppl 1):S43-S50.
- doi: 10.4111/icu.2020.61.S1.S43
The human gastrointestinal microbiome contains commensal bacteria and other microbiota that have been gaining increasing attention in the context of cancer development and response to treatment. Microbiota play a role... -
- CITED
-
- Close
- SHARE
-
- Close
- The changing landscape in the management of newly diagnosed castration sensitive metastatic prostate cancer
-
Parker DC, Cookson MS
- KMID: 2469121
- Investig Clin Urol.
- 2020 Feb;61(Suppl 1):S3-S7.
- doi: 10.4111/icu.2020.61.S1.S3
Metastatic prostate cancer is a heterogeneous disease entity. Men without prior androgen deprivation therapy exposure are termed metastatic castration sensitive prostate cancer (mCSPC). The goal of this article is to... -
- CITED
-
- Close
- SHARE
-
- Close
- The Use of Gonadotropin-Releasing Hormone Agonist Does Not Affect the Development of Cardiovascular Disease in Prostate Cancer Patients: a Nationwide Population-Based Cohort Study
-
Shim M, Bang WJ, Oh CY, Lee YS, Jeon SS, Ahn H, Ju YS, Cho JS
- KMID: 2468523
- J Korean Med Sci.
- 2020 Feb;35(4):e47.
- doi: 10.3346/jkms.2020.35.e47
BACKGROUND: The objective of this study was to investigate whether androgen deprivation therapy (ADT) with gonadotropin-releasing hormone agonist (GnRHa) in prostate cancer (Pca) patients is associated with cardiovascular disease in... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of 5α-reductase inhibitors on the efficiency of thulium:yttrium-aluminium-garnet (RevoLix®) vaporesection for treating benign prostatic hyperplasia
-
Chung JS, Seo WI, Oh CK, Kim SC, Park MC, Park SH, Yu J, Lee CH, Kim W, Park TY, Min KS, Chung JI
- KMID: 2466794
- Investig Clin Urol.
- 2020 Jan;61(1):67-74.
- doi: 10.4111/icu.2020.61.1.67
PURPOSE: Preoperative use of 5α-reductase inhibitors (5ARIs) may cause fibrosis of the prostate tissue and reduce the efficiency of thulium laser surgery for treating benign prostate hyperplasia (BPH). Thus, we... -
- CITED
-
- Close
- SHARE
-
- Close
- Preoperative prostate health index and %p2PSA as the significant biomarkers of postoperative pathological outcomes of prostate cancer in Korean males: A prospective multi-institutional study
-
Park H, Lee SW, Song G, Kang TW, Jung JH, Chung HC, Kim SJ, Park JY, Shin TY, Kim JH
- KMID: 2466791
- Investig Clin Urol.
- 2020 Jan;61(1):42-50.
- doi: 10.4111/icu.2020.61.1.42
PURPOSE: To evaluate the clinical utility of percentage of serum prostate-specific antigen (proPSA) to free PSA (%p2PSA) and the prostate health index (PHI) for predicting aggressive pathological outcomes of radical... -
- CITED
-
- Close
- SHARE
-
- Close
- Subclassification of pathologically organ-confined (pT2) prostate cancer does not significantly predict postoperative outcomes in Korean males
-
Lee MH, Lee S, Hong SK, Byun SS, Lee SE
- KMID: 2466790
- Investig Clin Urol.
- 2020 Jan;61(1):35-41.
- doi: 10.4111/icu.2020.61.1.35
PURPOSE: We evaluated the prognostic association of pT2 subclassification with the oncological outcomes in patients with prostate cancer (PCa) who underwent radical prostatectomy (RP) in South Korea. MATERIALS AND METHODS: We... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of prostate cancer detection rates of various prostate biopsy methods for patients with prostate-specific antigen levels of < 10.0 ng/mL in real-world practice
-
Oh KT, Koo KC, Chung BH, Lee KS
- KMID: 2466789
- Investig Clin Urol.
- 2020 Jan;61(1):28-34.
- doi: 10.4111/icu.2020.61.1.28
PURPOSE: Several strategies of prostate biopsy (PBx) have been introduced to improve prostate cancer (PCa) detection rates. However, studies comparing cancer detection rates (CDRs) according to biopsy methods in real-world... -
- CITED
-
- Close
- SHARE
-
- Close
- Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting
-
Jung SI, Kim MS, Jeong CW, Kwak C, Hong SK, Kang SH, Joung JY, Lee SH, Yun SJ, Kim TH, Park SW, Jeon SS, Kang M, Lee JY, Chung BH, Hong JH, Ahn H, Kim CS, Kwon DD
- KMID: 2466788
- Investig Clin Urol.
- 2020 Jan;61(1):19-27.
- doi: 10.4111/icu.2020.61.1.19
PURPOSE: This study aimed to evaluate the clinical efficacy of enzalutamide in chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) patients using real-world data from Korean patients. MATERIALS AND METHODS: We retrospectively reviewed... -
- CITED
-
- Close
- SHARE
-
- Close
- Lessons learned from 12,000 robotic radical prostatectomies: Is the journey as important as the outcome?
-
Kang SG, Shim JS, Onol F, Bhat KR, Patel VR
- KMID: 2466786
- Investig Clin Urol.
- 2020 Jan;61(1):1-10.
- doi: 10.4111/icu.2020.61.1.1
Robotic radical prostatectomy (RARP) is a standardized treatment for localized prostate cancer, which provides better functional outcomes and similar oncological outcomes compared to open approaches. Here, we share our experience... -
- CITED
-
- Close
- SHARE
-
- Close
- The Novel Method to Reduce Catheter-Related Bladder Discomfort after Transurethral Prostate Surgery
-
Shin YS, Doo AR, Park HJ
- KMID: 2465419
- World J Mens Health.
- 2020 Jan;38(1):137-138.
- doi: 10.5534/wjmh.190069
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Testosterone Replacement Therapy for Patients with Hypogonadism after High Dose-Rate Brachytherapy for High-Risk Prostate Cancer: A Report of Six Cases and Literature Review
-
Kadomoto S, Shigehara , Iwamoto H, Yaegashi H, Izumi K, Kadono Y, Mizokami A
- KMID: 2465418
- World J Mens Health.
- 2020 Jan;38(1):132-136.
- doi: 10.5534/wjmh.180130
We had six cases of patients who were treated with long-term testosterone replacement therapy (TRT) after high dose-rate (HDR) brachytherapy and androgen deprivation therapy for high-risk prostate cancer. All patients... -
- CITED
-
- Close
- SHARE
-
- Close
